End-of-day quote
Taiwan S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
253.5
TWD
|
-2.12%
|
|
+7.64%
|
+16.82%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,177
|
17,924
|
13,671
|
15,970
|
-
|
-
|
Enterprise Value (EV)
1 |
12,177
|
17,924
|
13,671
|
15,752
|
15,544
|
15,970
|
P/E ratio
|
27.5
x
|
25.7
x
|
45.3
x
|
25.4
x
|
19.7
x
|
-
|
Yield
|
-
|
-
|
-
|
2.01%
|
2.56%
|
3.24%
|
Capitalization / Revenue
|
-
|
6.45
x
|
5.7
x
|
4.68
x
|
4.02
x
|
3.22
x
|
EV / Revenue
|
-
|
6.45
x
|
5.7
x
|
4.62
x
|
3.91
x
|
3.22
x
|
EV / EBITDA
|
-
|
17.1
x
|
18.6
x
|
12.1
x
|
10.1
x
|
8.32
x
|
EV / FCF
|
-
|
-
|
-
|
42.9
x
|
31.3
x
|
-
|
FCF Yield
|
-
|
-
|
-
|
2.33%
|
3.19%
|
-
|
Price to Book
|
-
|
-
|
-
|
4.65
x
|
4.03
x
|
-
|
Nbr of stocks (in thousands)
|
54,727
|
63,000
|
63,000
|
63,000
|
-
|
-
|
Reference price
2 |
222.5
|
284.5
|
217.0
|
253.5
|
253.5
|
253.5
|
Announcement Date
|
3/10/22
|
3/8/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
2,778
|
2,398
|
3,409
|
3,976
|
4,953
|
EBITDA
1 |
-
|
1,046
|
736.8
|
1,301
|
1,540
|
1,920
|
EBIT
1 |
-
|
709.9
|
332.1
|
754.8
|
992.1
|
1,244
|
Operating Margin
|
-
|
25.56%
|
13.85%
|
22.14%
|
24.95%
|
25.12%
|
Earnings before Tax (EBT)
1 |
-
|
712.8
|
296.1
|
728
|
970
|
-
|
Net income
1 |
443.6
|
617.4
|
301.6
|
628
|
810
|
-
|
Net margin
|
-
|
22.23%
|
12.58%
|
18.42%
|
20.37%
|
-
|
EPS
2 |
8.080
|
11.07
|
4.790
|
9.970
|
12.85
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
367
|
496
|
-
|
FCF margin
|
-
|
-
|
-
|
10.77%
|
12.48%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
28.2%
|
32.22%
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
58.44%
|
61.23%
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
5.093
|
6.498
|
8.210
|
Announcement Date
|
3/10/22
|
3/8/23
|
2/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
716.6
|
685.5
|
525.8
|
535.6
|
647.6
|
688.7
|
814.5
|
822.1
|
865
|
907.6
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
200.9
|
182.8
|
193.5
|
200.7
|
208.4
|
EBIT
1 |
203.3
|
154.1
|
34.51
|
88.01
|
113.2
|
96.4
|
166.7
|
176.1
|
191.7
|
209.6
|
Operating Margin
|
28.37%
|
22.48%
|
6.56%
|
16.43%
|
17.48%
|
14%
|
20.46%
|
21.42%
|
22.16%
|
23.09%
|
Earnings before Tax (EBT)
1 |
-
|
131.8
|
23.2
|
82.3
|
114.3
|
76.23
|
157.3
|
167.3
|
185.3
|
205.7
|
Net income
1 |
-
|
123.9
|
39.05
|
56.88
|
99.7
|
106
|
138
|
144
|
163.5
|
182.5
|
Net margin
|
-
|
18.07%
|
7.43%
|
10.62%
|
15.4%
|
15.39%
|
16.94%
|
17.52%
|
18.9%
|
20.11%
|
EPS
2 |
-
|
2.090
|
0.6200
|
0.9000
|
1.580
|
1.680
|
2.190
|
2.290
|
2.595
|
2.900
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/14/22
|
3/8/23
|
5/10/23
|
8/10/23
|
11/9/23
|
2/29/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
219
|
427
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
367
|
496
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
19.7%
|
21.4%
|
24.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
12.5%
|
14.8%
|
-
|
Assets
1 |
-
|
-
|
-
|
5,020
|
5,473
|
-
|
Book Value Per Share
2 |
-
|
-
|
-
|
54.50
|
63.00
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
600
|
720
|
-
|
Capex / Sales
|
-
|
-
|
-
|
17.6%
|
18.11%
|
-
|
Announcement Date
|
3/10/22
|
3/8/23
|
2/29/24
|
-
|
-
|
-
|
Last Close Price
253.5
TWD Average target price
301.3
TWD Spread / Average Target +18.87% Consensus |
1st Jan change
|
Capi.
|
---|
| +16.82% | 501M | | +8.32% | 38.89B | | -5.87% | 17.87B | | -16.61% | 2.37B | | -16.74% | 1.48B | | +32.16% | 1.24B | | -34.97% | 761M | | -34.97% | 738M | | -7.58% | 672M | | +25.66% | 509M |
Glasses, Spectacles & Contact Lenses
|